The omega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential components of the human diet and have a broad range of health benefits. Furthermore, they may also be beneficial [...]
DHA or docosahexaenoic acid is an omega-3 fatty acid which is essential for the growth and development of the brain in infants and is required for maintenance of normal brain function in adults. Based on [...]
Dyslipidemia is a common side effect of atypical antipsychotics and, for a significant number of patients, may limit the acceptabillily of this class of drugs as an option for long-term treatment. This open trial tested [...]
Women with psychiatric disorders represent an at-risk population for premature delivery and other obstetrical complications. This study assesses the association between omega-3 fatty acid use and length of gestation. In an unadjusted model, there was [...]
Atypical antipsychotics are increasingly used to treat psychiatric disorders such as bipolar disorder or schizophrenia. In spite of the important role they play for many patients in treating serious psychiatric disorders, atypicals have been associated with negative side effects that may worsen a patient's cardiovascular health profile. This includes a greater risk for weight gain, glucose dysregulation/diabetes, and dyslipidemia (elevated triglycerides/cholesterol).
